Abstract
Autoimmune disorders currently number more than 80 and have the potential for rising higher. Intravenous chemotherapy drugs, including antineoplastic and biologic agents, have long been associated with the treatment of malignant diseases. Because intravenous "chemotherapy" drugs are also included as treatment options for these disorders, more nononcology nurses are expected to possess the knowledge and skill to administer and manage these therapies. Issues such as drug knowledge, safe handling, disposal, side effect management, and patient education must be a part of the administering nurse's education and competency.